Health Care Equipment & Services

Guardant Health’s July 1 insider buys signal strong leadership confidence in its liquid‑biopsy growth, underlining new coverage deals and tech advantages.

Zimmer Biomet insider buying signals confidence in its Bengaluru AI‑driven R&D hub, offering investors a long‑term growth story backed by early safety data.

SeaStar Medical insider purchases reveal executive confidence in its respiratory & renal device pipeline – a promising signal for investors and clinicians.

Insider buying fuels optimism for Molina Healthcare’s global pivot, as executives pile up shares amid divestiture plans and tech‑driven growth.

Investor insights: Hinge Health CFO’s July insider sales show routine cash‑flow moves, not a confidence loss. Learn why the pattern matters.

Modular Medical insider buys hint at confidence amid FDA hopes for its Pivot™ patch pump—investors weigh dilution risk, revenue trends, and payer strategies.

Alignment Healthcare insider buy signals strong management confidence, while recent sales show strategic liquidity; a balanced view for investors.

Phreesia insiders boost shares at 85% ESPP discount, signaling confidence in a near‑term rebound of its healthcare software platform.

Zimmer Biomet insider buy: Hagemann’s phantom‑stock purchase signals confidence in AI‑driven robotics, India R&D, and long‑term upside for investors.

Orchestra BioMed insider sale: 15k shares sold under a Rule 10b5‑1 plan at $4.27—routine liquidity move amid rising stock, not a sign of distress.